Holen Sie sich die Stockscreener-App
373.36
1.13%
4.17
Vorhandelsmarkt:
373.00
-0.36
-0.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$369.19
Offen:
$370.88
24-Stunden-Volumen:
2.20M
Relative Volume:
0.77
Marktkapitalisierung:
$201.24B
Einnahmen:
$36.74B
Nettoeinkommen (Verlust:
$7.71B
KGV:
26.23
EPS:
14.2333
Netto-Cashflow:
$8.10B
1W Leistung:
+2.39%
1M Leistung:
+13.00%
6M Leistung:
+25.94%
1J Leistung:
+28.23%
1-Tages-Spanne:
$369.00
$374.77
1-Wochen-Bereich:
$361.00
$374.77
52-Wochen-Spanne:
$261.43
$385.12
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, AZN, NVS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
373.36 | 198.99B | 36.74B | 7.71B | 8.10B | 14.23 |
|
LLY
Lilly Eli Co
|
1,036.05 | 981.09B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
243.33 | 586.69B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
232.86 | 409.15B | 61.16B | 4.20B | 19.68B | 2.3671 |
|
AZN
Astrazeneca Plc
|
209.48 | 318.66B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
166.17 | 311.22B | 54.72B | 14.02B | 15.32B | 7.1855 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | Fortgesetzt | UBS | Buy |
| 2025-12-05 | Hochstufung | Erste Group | Hold → Buy |
| 2025-11-24 | Fortgesetzt | Truist | Hold |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-09-03 | Fortgesetzt | Raymond James | Mkt Perform |
| 2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Amgen Stock Is Up 14% This Year on Dual Drug Approvals. Can the Rally Hold? - TIKR.com
First National Bank of Omaha Purchases Shares of 40,836 Amgen Inc. $AMGN - MarketBeat
Crestwood Advisors Group LLC Boosts Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc Files For Four-Part Senior Notes Offering Of Up To $4 Bln - TradingView
Amgen’s Uplizna now approved in EU to treat most adults with gMG - Myasthenia Gravis News
NEOS Investment Management LLC Increases Stock Position in Amgen Inc. $AMGN - MarketBeat
Skandinaviska Enskilda Banken AB publ Lowers Stake in Amgen Inc. $AMGN - MarketBeat
Zions Bancorporation National Association UT Sells 10,088 Shares of Amgen Inc. $AMGN - MarketBeat
Vanguard Group Inc. Purchases 165,281 Shares of Amgen Inc. $AMGN - MarketBeat
Public Sector Pension Investment Board Has $13.34 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Holdings Lowered by Fifth Third Bancorp - MarketBeat
Amgen Inc. (AMGN) Stock Analysis: Evaluating the Performance and Growth Potential of a Biotech Giant - DirectorsTalk Interviews
Amgen Inc (AMGN) Stock Price, Trades & News - GuruFocus
Why Amgen Inc. stock is seen as undervaluedWeekly Profit Analysis & Safe Capital Growth Tips - mfd.ru
Shell Asset Management Co. Has $2.82 Million Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by State of New Jersey Common Pension Fund D - MarketBeat
A Look At Amgen (AMGN) Valuation After Strong Q4 Results And New UPLIZNA Approval - simplywall.st
PNC Financial Services Group Inc. Increases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
HighTower Advisors LLC Grows Position in Amgen Inc. $AMGN - MarketBeat
ABN Amro Investment Solutions Sells 8,219 Shares of Amgen Inc. $AMGN - MarketBeat
Aberdeen Group plc Sells 76,076 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Downgraded to "Hold" Rating by Freedom Capital - MarketBeat
BTC Capital Management Inc. Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Assetmark Inc. Buys 10,886 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Position Lifted by Ameritas Advisory Services LLC - MarketBeat
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight - GuruFocus
Amgen (AMGN) Files for Automatic Mixed Securities Shelf Registra - GuruFocus
AMGEN INC SEC 10-K Report - TradingView
AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT - marketscreener.com
Here's What Argus Research and Guggenheim Are Saying About Amgen Inc. (AMGN) - Bitget
Amgen wins new European approval for Uplizna in generalised myasthenia gravis - European Pharmaceutical Review
Here’s what Argus Research and Guggenheim are saying about Amgen Inc. (AMGN) - MSN
Here’s What Argus Research and Guggenheim Are Saying About Amgen Inc. (AMGN) - Yahoo Finance
Amgen wins European approval to challenge argenx and UCB for autoimmune market - European Biotechnology Magazine
Amgen Inc. $AMGN Shares Sold by Savvy Advisors Inc. - MarketBeat
LSV Asset Management Raises Holdings in Amgen Inc. $AMGN - MarketBeat
Krilogy Financial LLC Takes $1.25 Million Position in Amgen Inc. $AMGN - MarketBeat
Baader Bank Aktiengesellschaft Lowers Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stake Lessened by Atria Investments Inc - MarketBeat
UPLIZNA’s Expanded EU Use in Autoimmune Disease Could Be A Game Changer For Amgen (AMGN) - simplywall.st
Amgen Conference: UPLIZNA Phase III Plans, Daxdilimab Lupus Data, and TEZSPIRE Expansion Update - MarketBeat
AMGN: Advancing late-stage trials and expanding TSLP-targeted therapies, with major data readouts ahead - TradingView
Traders Buy Large Volume of Amgen Call Options (NASDAQ:AMGN) - MarketBeat
Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.52 - Yahoo Finance
Amgen wins EC approval for Uplizna in gMG - The Pharma Letter
Amgen wins EC approval for Uplinza in gMG - The Pharma Letter
Can Amgen Inc. reach all time highs this yearQuarterly Profit Summary & Long-Term Growth Portfolio Plans - mfd.ru
Varma Mutual Pension Insurance Co Buys 7,300 Shares of Amgen Inc. $AMGN - MarketBeat
EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS - PR Newswire
Leuthold Group LLC Purchases New Stake in Amgen Inc. $AMGN - MarketBeat
Stratos Wealth Partners LTD. Has $8.83 Million Stake in Amgen Inc. $AMGN - MarketBeat
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.19%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):